Story provided by Alex Moe, WisBusiness.com. InvivoSciences, a pre-clinical stage biotech firm based in Madison, is gearing up for a potential FDA application for a heart failure drug and companion…

InvivoSciences announced today it is the recipient of a $700,000 SBIR grant. According to a release, the money from the National Institute of Aging will help InvivoSciences collaborate with the Torrey Pines…

InvivoSciences and New Jersey-based Hamamatsu today announced a joint collaboration that ultimately may help accelerate preclinical drug discovery in regenerative medicine. According to a release, technology developed by Hamamatsu will be…

InvivoSciences, Inc. and Torrey Pines Institute for Molecular Studies (TPIMS) announced today they will be working together to accelerate drug discovery in cardiac disease. “We are especially proud and pleased…